methamphetamine has been researched along with cysteamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Heim, F | 1 |
| Matsuoka, N; Satoh, M; Yamaguchi, I | 1 |
1 review(s) available for methamphetamine and cysteamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for methamphetamine and cysteamine
| Article | Year |
|---|---|
[The correlations between aging and drug effects (author's transl)].
Topics: Age Factors; Aging; Animals; Caffeine; Cysteamine; Energy Metabolism; Glycolysis; Hepatectomy; Humans; Inactivation, Metabolic; Liver; Methamphetamine; Oxygen Consumption; Pharmacology; Testosterone | 1976 |
Role of somatostatin in the augmentation of hippocampal long-term potentiation by FR121196, a putative cognitive enhancer.
Topics: Animals; Catecholamines; Cognition; Cysteamine; Electrophysiology; Guinea Pigs; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Methamphetamine; Nerve Fibers; Neural Pathways; Physostigmine; Piperazines; Scopolamine; Somatostatin; Sulfonamides | 1993 |